We observed that expression of FHOD1 is generally higher in thyroid tumors than in head and neck cancers, suggesting that Q61 may be more advantageous in thyroid cancer in part because of tumor type specific FHOD1 activity (Fig. 6, Additional file 4: Figure S4). The gene discussed is FHOD1; the disease is thyroid gland carcinoma.